Great Lakes Advisors LLC Increases Stake in Bath & Body Works, Inc. $BBWI

Great Lakes Advisors LLC boosted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 1,387.2% during the first quarter, Holdings Channel.com reports. The institutional investor owned 79,447 shares of the company’s stock after buying an additional 74,105 shares during the period. Great Lakes Advisors LLC’s holdings in Bath & Body Works were worth $2,409,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Sciencast Management LP raised its stake in shares of Bath & Body Works by 48.9% in the first quarter. Sciencast Management LP now owns 116,219 shares of the company’s stock valued at $3,524,000 after acquiring an additional 38,183 shares in the last quarter. Goldman Sachs Group Inc. raised its position in Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company’s stock valued at $19,586,000 after purchasing an additional 87,529 shares in the last quarter. Dynamic Technology Lab Private Ltd raised its position in Bath & Body Works by 50.5% in the 1st quarter. Dynamic Technology Lab Private Ltd now owns 102,040 shares of the company’s stock valued at $3,094,000 after purchasing an additional 34,231 shares in the last quarter. Teza Capital Management LLC grew its position in shares of Bath & Body Works by 88.3% during the first quarter. Teza Capital Management LLC now owns 16,333 shares of the company’s stock worth $495,000 after buying an additional 7,658 shares in the last quarter. Finally, Shellback Capital LP increased its stake in shares of Bath & Body Works by 67.0% during the first quarter. Shellback Capital LP now owns 668,000 shares of the company’s stock worth $20,254,000 after buying an additional 268,000 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Price Performance

NYSE BBWI opened at $28.15 on Thursday. The firm’s fifty day moving average price is $30.53 and its 200 day moving average price is $30.35. Bath & Body Works, Inc. has a 12 month low of $24.94 and a 12 month high of $41.87. The company has a market capitalization of $5.81 billion, a price-to-earnings ratio of 8.35, a price-to-earnings-growth ratio of 0.97 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm had revenue of $1.55 billion during the quarter, compared to analysts’ expectations of $1.55 billion. During the same period in the previous year, the company earned $0.37 earnings per share. Bath & Body Works’s quarterly revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date was Friday, August 22nd. Bath & Body Works’s dividend payout ratio (DPR) is currently 23.74%.

Analyst Upgrades and Downgrades

BBWI has been the subject of a number of recent research reports. The Goldman Sachs Group decreased their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a “buy” rating for the company in a research note on Friday, May 30th. UBS Group reduced their price objective on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a report on Friday, August 29th. Telsey Advisory Group reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Bath & Body Works in a research report on Thursday, August 28th. Wall Street Zen downgraded shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Finally, Barclays raised their price target on Bath & Body Works from $30.00 to $32.00 and gave the company an “equal weight” rating in a research note on Friday, August 29th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $41.62.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.